Drugs / JYEST cell injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07476014 | Feb 2026 → Jan 2029 expected | disease related to hematopoietic stem cell transplant | Institute of Hematology & Blood Diseases Hospital, China | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JYEST cell injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07476014 ↗ |
| Modality | Cell therapy | “Use of Donor-derived EBV-specific T Cells” NCT07476014 ↗ |
| Route | Intravenous | “dosage form: intravenous infusion.” NCT07476014 ↗ |